Introduced January 9, 2025 by James E. Banks · Last progress January 9, 2025
The bill strengthens U.S. leverage to deter and punish chemical/biological misuse through faster, targeted sanctions and suspension authorities while increasing risks of diplomatic retaliation, economic disruption to businesses and research, and added fairness and resource challenges for the executive branch.
Taxpayers and U.S. policymakers gain stronger, targeted tools to deter and punish chemical/biological misuse by allowing sanctions on culpable countries and named foreign individuals.
Congress, the public, and the executive branch get faster, clearer procedures and mandatory reporting (including a 60‑day decision window and 120–210 day certifications), improving accountability and encouraging more evidence‑based, treaty‑aware determinations.
Hospitals, health systems, and U.S. institutions can be protected more quickly by suspending scientific cooperation, exports, procurement, and by authorizing targeted termination of foreign assistance (while preserving urgent humanitarian food/agriculture aid).
Middle‑class families, taxpayers, and exporters face greater diplomatic friction and risk of retaliation (trade restrictions, reduced cooperation) as broader sanction and individual‑targeting authorities increase tensions with other countries.
Taxpayers, small businesses, exporters, and financial institutions may incur direct economic costs from expanded sanctions, export/procurement bans, financial transaction prohibitions, and greater compliance burdens.
Hospitals, academic partners, and researchers may see disrupted scientific cooperation and delays to medical and public‑health projects when cooperation or exports are suspended.
Based on analysis of 5 sections of legislative text.
Creates an individual-focused determination process for chemical/biological acts and requires immediate suspensions and export/procurement restrictions plus mandatory sanctions if a foreign government fails to respond.
Creates a new, individual-focused sanctions and reporting regime tied to chemical and biological programs: the President must determine within 60 days whether a foreign government official, employee, or agent committed a covered chemical/biological act occurring on or after enactment, and if so must take immediate suspension and export/procurement restrictions and later impose mandatory sanctions if the foreign government fails to address the act. The law also expands the underlying statutory purposes, adds required reporting content and procedures for individual determinations, and makes a narrow conforming change to an existing cross-reference. The measure directs near-term actions (suspending scientific cooperation, blocking certain exports and U.S. procurement) within 30 days of a determination, requires a 120-day report to Congress assessing foreign remedial steps and treaty compliance, and mandates at least two specified penalties when a foreign government does not adequately respond. It applies to covered acts on or after enactment and creates new evidence and procedural considerations the President must weigh when making individual culpability findings.